Overview

The Effect of 6% Hydroxyethyl Starch 130/0.4 on Blood Loss and Coagulation in Patients Medicated With Antiplatelet Agents Prior to Off-Pump Coronary Bypass Graft Surgery

Status:
Completed

Trial end date:
2010-02-01

Target enrollment:

Participant gender:

Summary

HES 130/0.4 significantly solution will not affect on coagulation and blood loss in patients medicated with antiplatelet agents prior to off-pump coronary bypass surgery (OPCAB).

Phase:

Phase 4

Details

Lead Sponsor:

Yonsei University

Treatments:

Hydroxyethyl Starch Derivatives
Platelet Aggregation Inhibitors